INmune Bio, Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
8.06
+0.42 (5.50%)
May 13, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20
INKmune and DN-TNF Product Platform
155.00K
Log In
Log In
Log In
INKmune and DN-TNF Product Platform Growth
-58.56%
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20
United States
155.00K
Log In
Log In
Log In
United States Growth
-58.56%
Log In
Log In
Log In